AK

Arvind Kumar Singh

Active Director Director DIN 01401198
DIN 01401198 First appointment Sep 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2010
Shareholding value •••• Premium profile

About Arvind Kumar Singh

Data last updated:

Arvind Kumar Singh is a Director at Macmed Pharmaceuticals Private Limited (since 2010). The company operates in Trading. Macmed Pharmaceuticals Private Limited reported revenue of ₹6.4 Lakh (FY 2025).

DIN 01401198
Primary Designation Director
Industry Trading
First Appointment 15 Sep 2010
Oldest Company Age 16 yrs
Largest company Macmed Pharmaceuticals Private Limited · ₹6.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20102010₹6.4 Lakh (FY 2025)Active

Board colleagues of Arvind Kumar Singh

Directorship timeline

Open interactive timeline →
Macmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arvind Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Kumar Singh

Arvind Kumar Singh currently holds 1 directorship: Macmed Pharmaceuticals Private Limited (Director, since 15 Sep 2010, revenue ₹6.4 Lakh (FY 2025)).

Arvind Kumar Singh was first appointed on 15 Sep 2010 as Director at Macmed Pharmaceuticals Private Limited.

The current boards of Arvind Kumar Singh's companies include Shailesh Kumar Singh (Macmed Pharmaceuticals Private Limited), Shatrudhna Singh Maurya (Macmed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available